Susquehanna International Group’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73
Closed -$6K 13845
2022
Q3
$6K Buy
73
+6
+9% +$861 ﹤0.01% 12864
2022
Q2
$11K Sell
67
-127
-65% -$30.1K ﹤0.01% 12498
2022
Q1
$73K Sell
194
-175
-47% -$59.1K ﹤0.01% 12108
2021
Q4
$143K Sell
369
-48
-12% -$27.9K ﹤0.01% 11846
2021
Q3
$312K Buy
417
+76
+22% +$63.6K ﹤0.01% 10518
2021
Q2
$356K Buy
341
+104
+44% +$124K ﹤0.01% 10400
2021
Q1
$353K Buy
237
+97
+69% +$141K ﹤0.01% 10270
2020
Q4
$149K Sell
140
-113
-45% -$103K ﹤0.01% 10257
2020
Q3
$182K Buy
253
+161
+175% +$154K ﹤0.01% 9533
2020
Q2
$63K Buy
+92
New +$41.3K ﹤0.01% 9686

Other funds holding YCBD

Susquehanna International Group's YCBD Position: Q1 2026 in Review

Susquehanna International Group sold out of cbdMD (YCBD) in Q1 2026, closing a stake of 11,966 shares — an estimated $16.2K sold.

Susquehanna International Group first reported a position in YCBD in Q1 2020 and held it in 15 quarters. The position peaked at $1.39M in Q1 2021. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Susquehanna International Group reported no remaining cbdMD position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 11,966 cbdMD shares in Q1 2026, an estimated $16.2K.
  • Susquehanna International Group first reported a position in cbdMD in Q1 2020 and held it in 15 quarters.
  • Susquehanna International Group's cbdMD position peaked at $1.39M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.